9.43 USD
-0.32 (-3.28%)
9.43 USD
0 (0%)
AHCO gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. AHCO has a medium profitability rating, but doesn't score so well on its financial health evaluation. AHCO may be a bit undervalued, certainly considering the very reasonable score on growth
1. Profitability
1.1 Basic Checks
AHCO had positive earnings in the past year.
AHCO had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: AHCO reported negative net income in multiple years.
Each year in the past 5 years AHCO had a positive operating cash flow.
1.2 Ratios
The Return On Assets of AHCO (1.69%) is comparable to the rest of the industry.
AHCO has a better Return On Equity (4.83%) than 61.39% of its industry peers.
AHCO has a Return On Invested Capital of 4.53%. This is comparable to the rest of the industry: AHCO outperforms 52.48% of its industry peers.
AHCO had an Average Return On Invested Capital over the past 3 years of 4.25%. This is below the industry average of 9.22%.
The last Return On Invested Capital (4.53%) for AHCO is above the 3 year average (4.25%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.69% | ||
| ROE | 4.83% | ||
| ROIC | 4.53% |
ROA(3y)-4%
ROA(5y)-3.64%
ROE(3y)-12.78%
ROE(5y)-15.4%
ROIC(3y)4.25%
ROIC(5y)3.76%
1.3 Margins
With a decent Profit Margin value of 2.33%, AHCO is doing good in the industry, outperforming 64.36% of the companies in the same industry.
In the last couple of years the Profit Margin of AHCO has declined.
AHCO has a better Operating Margin (7.82%) than 72.28% of its industry peers.
In the last couple of years the Operating Margin of AHCO has grown nicely.
AHCO has a Gross Margin (25.32%) which is in line with its industry peers.
In the last couple of years the Gross Margin of AHCO has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.82% | ||
| PM (TTM) | 2.33% | ||
| GM | 25.32% |
OM growth 3Y1.95%
OM growth 5Y11.03%
PM growth 3Y-23.99%
PM growth 5YN/A
GM growth 3Y4.28%
GM growth 5Y4.45%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AHCO is destroying value.
The number of shares outstanding for AHCO has been increased compared to 1 year ago.
Compared to 5 years ago, AHCO has more shares outstanding
Compared to 1 year ago, AHCO has an improved debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 1.05, we must say that AHCO is in the distress zone and has some risk of bankruptcy.
AHCO has a worse Altman-Z score (1.05) than 68.32% of its industry peers.
The Debt to FCF ratio of AHCO is 9.48, which is on the high side as it means it would take AHCO, 9.48 years of fcf income to pay off all of its debts.
AHCO's Debt to FCF ratio of 9.48 is in line compared to the rest of the industry. AHCO outperforms 45.54% of its industry peers.
AHCO has a Debt/Equity ratio of 1.27. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.27, AHCO is not doing good in the industry: 63.37% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.27 | ||
| Debt/FCF | 9.48 | ||
| Altman-Z | 1.05 |
ROIC/WACC0.58
WACC7.83%
2.3 Liquidity
A Current Ratio of 1.33 indicates that AHCO should not have too much problems paying its short term obligations.
AHCO has a Current ratio (1.33) which is in line with its industry peers.
AHCO has a Quick Ratio of 1.09. This is a normal value and indicates that AHCO is financially healthy and should not expect problems in meeting its short term obligations.
AHCO's Quick ratio of 1.09 is in line compared to the rest of the industry. AHCO outperforms 44.55% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.33 | ||
| Quick Ratio | 1.09 |
3. Growth
3.1 Past
AHCO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 119.39%, which is quite impressive.
AHCO shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.23% yearly.
Looking at the last year, AHCO shows a very negative growth in Revenue. The Revenue has decreased by -19.72% in the last year.
The Revenue has been growing by 43.84% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)119.39%
EPS 3Y10.23%
EPS 5YN/A
EPS Q2Q%6.67%
Revenue 1Y (TTM)-19.72%
Revenue growth 3Y9.93%
Revenue growth 5Y43.84%
Sales Q2Q%1.79%
3.2 Future
AHCO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.59% yearly.
AHCO is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.27% yearly.
EPS Next Y36.57%
EPS Next 2Y37.29%
EPS Next 3Y30.76%
EPS Next 5Y20.59%
Revenue Next Year-0.24%
Revenue Next 2Y3.24%
Revenue Next 3Y5.33%
Revenue Next 5Y7.27%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 29.47 indicates a quite expensive valuation of AHCO.
The rest of the industry has a similar Price/Earnings ratio as AHCO.
AHCO is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.15, which is the current average of the S&P500 Index.
AHCO is valuated reasonably with a Price/Forward Earnings ratio of 8.34.
Based on the Price/Forward Earnings ratio, AHCO is valued cheaply inside the industry as 94.06% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 36.22. AHCO is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.47 | ||
| Fwd PE | 8.34 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, AHCO is valued cheaply inside the industry as 93.07% of the companies are valued more expensively.
95.05% of the companies in the same industry are more expensive than AHCO, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.99 | ||
| EV/EBITDA | 5.06 |
4.3 Compensation for Growth
AHCO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of AHCO may justify a higher PE ratio.
AHCO's earnings are expected to grow with 30.75% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.81
PEG (5Y)N/A
EPS Next 2Y37.29%
EPS Next 3Y30.76%
5. Dividend
5.1 Amount
No dividends for AHCO!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
9.43
-0.32 (-3.28%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners93.9%
Inst Owner Change-0.75%
Ins Owners1.82%
Ins Owner Change1.38%
Market Cap1.28B
Revenue(TTM)3.26B
Net Income(TTM)75.81M
Analysts81.43
Price Target13.52 (43.37%)
Short Float %8.73%
Short Ratio10.1
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-123.07%
Min EPS beat(2)-210.83%
Max EPS beat(2)-35.31%
EPS beat(4)1
Avg EPS beat(4)-384.03%
Min EPS beat(4)-1325.49%
Max EPS beat(4)35.5%
EPS beat(8)1
Avg EPS beat(8)-358.04%
EPS beat(12)3
Avg EPS beat(12)-235.24%
EPS beat(16)3
Avg EPS beat(16)-191.39%
Revenue beat(2)1
Avg Revenue beat(2)-0.88%
Min Revenue beat(2)-2.38%
Max Revenue beat(2)0.61%
Revenue beat(4)2
Avg Revenue beat(4)-0.19%
Min Revenue beat(4)-2.38%
Max Revenue beat(4)1.28%
Revenue beat(8)4
Avg Revenue beat(8)-0.23%
Revenue beat(12)5
Avg Revenue beat(12)-0.64%
Revenue beat(16)7
Avg Revenue beat(16)-0.16%
PT rev (1m)0.95%
PT rev (3m)0.95%
EPS NQ rev (1m)-9.74%
EPS NQ rev (3m)-15.09%
EPS NY rev (1m)1.69%
EPS NY rev (3m)-14.84%
Revenue NQ rev (1m)-1.81%
Revenue NQ rev (3m)-1.81%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.09%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.47 | ||
| Fwd PE | 8.34 | ||
| P/S | 0.39 | ||
| P/FCF | 5.99 | ||
| P/OCF | 2.24 | ||
| P/B | 0.81 | ||
| P/tB | N/A | ||
| EV/EBITDA | 5.06 |
EPS(TTM)0.32
EY3.39%
EPS(NY)1.13
Fwd EY11.99%
FCF(TTM)1.57
FCFY16.69%
OCF(TTM)4.2
OCFY44.56%
SpS24.04
BVpS11.6
TBVpS-8.93
PEG (NY)0.81
PEG (5Y)N/A
Graham Number9.14
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.69% | ||
| ROE | 4.83% | ||
| ROCE | 6.5% | ||
| ROIC | 4.53% | ||
| ROICexc | 4.66% | ||
| ROICexgc | 17.24% | ||
| OM | 7.82% | ||
| PM (TTM) | 2.33% | ||
| GM | 25.32% | ||
| FCFM | 6.55% |
ROA(3y)-4%
ROA(5y)-3.64%
ROE(3y)-12.78%
ROE(5y)-15.4%
ROIC(3y)4.25%
ROIC(5y)3.76%
ROICexc(3y)4.34%
ROICexc(5y)3.9%
ROICexgc(3y)17.05%
ROICexgc(5y)18.83%
ROCE(3y)6.1%
ROCE(5y)5.39%
ROICexgc growth 3Y0.25%
ROICexgc growth 5Y-13.24%
ROICexc growth 3Y18.04%
ROICexc growth 5Y-2.96%
OM growth 3Y1.95%
OM growth 5Y11.03%
PM growth 3Y-23.99%
PM growth 5YN/A
GM growth 3Y4.28%
GM growth 5Y4.45%
F-Score7
Asset Turnover0.73
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.27 | ||
| Debt/FCF | 9.48 | ||
| Debt/EBITDA | 3.16 | ||
| Cap/Depr | 94.9% | ||
| Cap/Sales | 10.93% | ||
| Interest Coverage | 2.41 | ||
| Cash Conversion | 90.37% | ||
| Profit Quality | 281.18% | ||
| Current Ratio | 1.33 | ||
| Quick Ratio | 1.09 | ||
| Altman-Z | 1.05 |
F-Score7
WACC7.83%
ROIC/WACC0.58
Cap/Depr(3y)94.46%
Cap/Depr(5y)82.09%
Cap/Sales(3y)11.04%
Cap/Sales(5y)9.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)119.39%
EPS 3Y10.23%
EPS 5YN/A
EPS Q2Q%6.67%
EPS Next Y36.57%
EPS Next 2Y37.29%
EPS Next 3Y30.76%
EPS Next 5Y20.59%
Revenue 1Y (TTM)-19.72%
Revenue growth 3Y9.93%
Revenue growth 5Y43.84%
Sales Q2Q%1.79%
Revenue Next Year-0.24%
Revenue Next 2Y3.24%
Revenue Next 3Y5.33%
Revenue Next 5Y7.27%
EBIT growth 1Y-29.64%
EBIT growth 3Y12.08%
EBIT growth 5Y59.71%
EBIT Next Year170.35%
EBIT Next 3Y49.37%
EBIT Next 5YN/A
FCF growth 1Y594.38%
FCF growth 3Y48.23%
FCF growth 5Y43.24%
OCF growth 1Y34.71%
OCF growth 3Y25.26%
OCF growth 5Y55.08%
ADAPTHEALTH CORP / AHCO FAQ
What is the ChartMill fundamental rating of ADAPTHEALTH CORP (AHCO) stock?
ChartMill assigns a fundamental rating of 5 / 10 to AHCO.
Can you provide the valuation status for ADAPTHEALTH CORP?
ChartMill assigns a valuation rating of 7 / 10 to ADAPTHEALTH CORP (AHCO). This can be considered as Undervalued.
How profitable is ADAPTHEALTH CORP (AHCO) stock?
ADAPTHEALTH CORP (AHCO) has a profitability rating of 6 / 10.
Can you provide the PE and PB ratios for AHCO stock?
The Price/Earnings (PE) ratio for ADAPTHEALTH CORP (AHCO) is 29.47 and the Price/Book (PB) ratio is 0.81.